IMCC IM Cannabis Corp.
IM Cannabis (IMCC) news
IM Cannabis Corp. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker IMCC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest IM Cannabis news
We have not published a story on IM Cannabis yet. When there is news, it will appear here.
IM Cannabis annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | C$54.7 million | C$54.0 million |
| Net income (loss) | -C$11.8 million | -C$11.8 million |
| Cash from operations | C$4.7 million | -C$1.1 million |
| Cash and equivalents | C$2.7 million | C$863,000 |
Questions about IM Cannabis
What is the ticker symbol of IM Cannabis?
IM Cannabis Corp. trades under the ticker IMCC on NASDAQ.
Where is IM Cannabis listed?
IM Cannabis Corp. is listed on NASDAQ.
Which country or territory is IM Cannabis listed under?
Our directory records IM Cannabis Corp. under United States.
Does aibio.space cover IM Cannabis?
aibio.space lists IM Cannabis Corp. among 2,820 public biotech companies and publishes its news here as stories appear.
Investor discussion: IM Cannabis
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
Stock chart
Listing details
- Company
- IM Cannabis Corp.
- Ticker
- IMCC
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio